NDC 76329-3352-01 - Sodium Bicarbonate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76329-3352
- Requested NDC
- 76329-3352-01
- Package NDCs from labels
- 76329-3352-1, 76329-3352-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sodium Bicarbonate Injection, USP | REMEDYREPACK INC. | 2026-08-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Sodium Bicarbonate - ProPharma Distribution | ProPharma Distribution | 2025-08-28 | HUMAN PRESCRIPTION DRUG LABEL |
| SODIUM BICARBONATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Sodium Bicarbonate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-23 | HUMAN PRESCRIPTION DRUG LABEL |
| Sodium Bicarbonate Injection, USP | International Medication Systems, Limited | nternational Medication Systems, Limited | 2021-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76329-3352-1 | Sodium Bicarbonate | 50 mL in 1 SYRINGE | INJECTION | 50 | 6 | |
| 76329-3352-1 | Sodium Bicarbonate | 1 in 1 CARTON | INJECTION | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76329-3352 | SODIUM BICARBONATE (SODIUM BICARBONATE) INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 6 | Current NDC, Legacy NDC, 2 package rows | 20211216_77698221-a01d-4568-a7bc-d3d4e982875d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76329-3352-1 | ML - Milliliter | 76329-3352 | 145127f4-d75d-4fc4-aa3e-c1587de2c790 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Sodium Bicarbonate | ACTIVE INGREDIENT | 8MDF5V39QO | SODIUM BICARBONATE (SODIUM BICARBONATE) INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 3 | |
| Bicarbonate Ion | ACTIVE MOIETY | HN1ZRA3Q20 | SODIUM BICARBONATE (SODIUM BICARBONATE) INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM Sodium bicarbonate (Nat Bicarb) | SODIUM BICARBONATE | BM Private Limited | 38044eae-7237-6add-e063-6294a90a827b | 2025-12-02 | Warnings | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Ajanta Pharma USA Inc. | bd84ca00-6352-4cb3-bce2-05f4a5005a94 | 2025-11-30 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Civica | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 2025-11-24 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Glenmark Pharmaceuticals Inc., USA | f38d0dfc-9bcc-4224-a202-885c9ad0beae | 2025-11-20 | Warnings, Adverse reactions | 8MDF5V39QO |
| Itch Eraser Sensitive | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 2250525a-45c2-42ea-e063-6394a90ac001 | 2025-11-18 | Warnings | 8MDF5V39QO |
| After Bite Kids | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 226c1420-d771-204f-e063-6294a90af9f6 | 2025-11-18 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | 8MDF5V39QO |
| After Bite X Tech | SODIUM BICARBONATE | Adventure Ready Brands | e9e49ab4-3e1f-9fd4-e053-2a95a90a775a | 2025-11-17 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 1484a825-40c6-a9c9-e063-6294a90a9ca4 | 2025-11-10 | Warnings | 8MDF5V39QO |
| GURUNANDA NASAL SALINE | NASAL WASH | GURUNANDA LLC | 27dbf0bf-c273-2108-e063-6394a90a0a09 | 2025-11-10 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 28152c9f-b15c-3707-e063-6394a90a70e9 | 2025-11-10 | Warnings | 8MDF5V39QO |
| QUABIC-300 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | c3cd7f0f-8d70-23af-e053-2a95a90a569b | 2025-11-10 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Henry Schein, Inc. | da484a2f-154f-48b4-8467-7a86729204c3 | 2025-11-07 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea20a5eb-641e-48cd-bcfa-74c04c45dfda | 2025-11-06 | Warnings, Adverse reactions | 792582 8MDF5V39QO |
| CEO-TWO | LAXATIVE | Beutlich Pharmaceuticals, LLC | 08670636-5795-4db0-e063-6294a90afa4b | 2025-11-05 | Warnings | 8MDF5V39QO |
| Omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Walgreen Company | 8753a131-f8b1-48e1-993b-73c1ee635fef | 2025-11-04 | Warnings | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | CVS Pharmacy | 186732a3-13b9-4ea2-ba54-424f63298a2e | 2025-11-04 | Warnings | 8MDF5V39QO |
| basic care omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Amazon.com Services LLC | 4587f491-04ef-4c31-b7b6-bfafd31776fb | 2025-11-04 | Warnings | 8MDF5V39QO |
| Omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | H E B | ddc8d73f-f4a1-42a7-89ee-420346820f61 | 2025-11-03 | Warnings | 8MDF5V39QO |
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.